Rising Biosciences Inc RBII
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.01 / $0.03
- Market Cap
- $668.73
- Volume/Avg
- 2.2 Mil / 263,442
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- —
Valuation
|
Metric
|
RBII
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RBII
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
RBII
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Kpvdfbrbfj | Nbmqgq | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Hfmhpnmvk | Ykl | $68.9 Bil | |
HLN
| Haleon PLC ADR | Dlhffgqs | Nxk | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Cqtxxvpv | Wtlvb | $14.8 Bil | |
VTRS
| Viatris Inc | Xmnfmxrsk | Xqjc | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Cbmgwkj | Sbcg | $11.9 Bil | |
CTLT
| Catalent Inc | Hvbwvbw | Jlqrfw | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Mzllnns | Yknw | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Rgnqrsln | Ncr | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hcbgygjr | Yxxzwv | $3.5 Bil |